Business
Single-shot Johnson & Johnson vaccine ‘highly effective’ in preventing severe COVID-19 – SBS News
In large clinical trials, the Johnson & Johnson vaccine’s efficacy against severe disease was 85.9 per cent in the United States, 81.7 per cent in South Africa,…
The single-shot Johnson & Johnson vaccine is highly effective in preventing severe COVID-19, including newer variants, according to documents released by the US Food and Drug Administration.
The news on Wednesday came as the US regulator was set to convene an independent panel Friday that will likely vote to authorise the vaccine, making it the third available in the country hit hardest by the coronavirus pandemic.
In large clinical trials, the Johnson & Johnson vaccine’s efficacy against severe…
-
General19 hours agoGerman backpacker Carolina Wilga found alive in WA’s outback
-
Noosa News22 hours agoAustralian NFL player Laki Tasi comes home to convince kids to switch codes
-
Business21 hours agoHow $1,000 a month in this ASX ETF could turn into $500,000
-
Noosa News21 hours agoInside the final hours before Australian lawyer Christopher Saines died in Thai massage parlour